Krüppel-like factor 4 mediates anti-proliferative effects of progesterone with G0/G1 arrest in human endometrial epithelial cells

Journal of Endocrinological Investigation

Volumn 33, Issue 10, 2010, Pages 745-750

  Shimizu, Y ^a   Takeuchi, T ^a   Mita, S ^a   Notsu, T ^a   Mizuguchi, K ^a   Kyo, S ^b  

^a MOCHIDA PHARMACEUTICAL CO   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cell proliferation; Dienogest; Endometrial epithelial cells; Kr ppel like factor 4; Progesterone

Indexed keywords

CYCLIN D1; DIENOGEST; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; PROGESTERONE; SMALL INTERFERING RNA;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

CELL PROLIFERATION; CELLS, CULTURED; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; G0 PHASE; G1 PHASE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENES, BCL-1; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PROGESTERONE; RECEPTORS, PROGESTERONE; RNA, SMALL INTERFERING;

EID: 79951597089     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7044     Document Type: Article

References (23)

1. Gadkar-Sable S, Shah C, Rosario G, Sachdeva G, Puri C. Progesterone receptors: various forms and functions in reproductive tissues. Front Biosci 2005, 10: 2118-30. (Pubitemid 40905287)
2. Surrey ES. The role of progestins in treating the pain of endometriosis. J Minim Invasive Gynecol 2006, 13: 528-34. (Pubitemid 44693481)
3. Lopez de la Osa Gonzalez E. Clinical response of abnormal endometrial growth to hormonal treatment. Ann N Y Acad Sci 1994, 734: 306-9.
4. Sutherland RL, Prall OWJ, Watts CKW, Musgrove EA. Estrogen and progestin regulation of cell cycle progression. J Mammary Gland Biol Neoplasia 1998, 3: 63-72. (Pubitemid 128513220)
5. Sasagawa S, Shimizu Y, Kami H, et al. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids 2008, 73: 222-31.
6. Shimizu Y, Takeuchi T, Mita S, et al. Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression. Mol Hum Reprod 2009, 15: 693-701.
7. Boonyaratanakornkit V, Bi Y, Rudd M, Edwards DP. The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression. Steroids 2008, 73: 922-8.
8. McConnell BB, Ghaleb AM, Nandan MO, Yang VW. The diverse functions of Krüppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 2007, 29: 549-57. (Pubitemid 46903942)
9. Chen X, Johns DC, Geiman DE, et al. Krüppel-like factor 4 (gut-enriched Krüppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J Biol Chem 2001, 276: 30423-8.
10. Bieker JJ. Krüppel-like factors: three fingers in many pies. J Biol Chem 2001, 276: 34355-8. (Pubitemid 37384419)
11. Shie JL, Chen ZY, Fu M, Pestell RG, Tseng CC. Gut-enriched Krüppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res 2000, 28: 2969-76. (Pubitemid 30599273)
12. Foster KW, Liu Z, Nail CD, et al. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene 2005, 24: 1491-500. (Pubitemid 40396079)
13. Wei D, Gong W, Kanai M, et al. Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 2005, 65: 2746-54. (Pubitemid 40490076)
14. Yang Y, Goldstein BG, Chao HH, Katz JP. KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol Ther 2005, 4: 1216-21.
15. Motokura T, Arnold A. PRADVcyclin D1 proto-oncogene: genomic organization, 5′ DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes Chromosomes Cancer 1993, 7: 89-95. (Pubitemid 23163655)
16. Kyo S, Nakamura M, Kiyono T, et al. Successful immortalization of endometrial glandular cells with normal structural and functional characteristics. Am J Pathol 2003, 163: 2259-69. (Pubitemid 37466470)
17. Yoshimura T, Sumida T, Liu S, et al. Growth inhibition of human salivary gland tumor cells by introduction of progesterone (Pg) receptor and Pg treatment. Endocr Relat Cancer 2007, 14: 1107-16. (Pubitemid 351252442)
18. Ishibashi H, Suzuki T, Suzuki S, et al. Progesterone receptor in non-small cell lung cancer - a potent prognostic factor and possible target for endocrine therapy. Cancer Res 2005, 65: 6450-8. (Pubitemid 40994434)
19. Kawaguchi M, Watanabe J, Hamano M, et al. Medroxyprogesterone acetate stimulates cdk inhibitors, p21 and p27, in endometrial carcinoma cells transfected with progesterone receptor-B cDNA. Eur J Gynaecol Oncol 2006, 27: 33-8.
20. KiP1 by progestins is involved in the growth suppression of the normal and malignant human endometrial glandular cells. Endocrinology 2001, 142: 4182-8. (Pubitemid 32907043)
21. Kip1 association with cyclin E-Cdk2. J Biol Chem 2001, 276: 47675-83.
22. Kip1. Mol Endocrinol 1997, 11: 1593-607. (Pubitemid 27435408)
23. Yudt MR, Berrodin TJ, Jelinsky SA, et al. Selective and opposing actions of progesterone receptor isoforms in human endometrial stromal cells. Mol Cell Endocrinol 2006, 247: 116-26. (Pubitemid 43277715)